Pfizer Inks $1.95B Deal To Provide COVID-19 Vaccine Doses
The U.S. government signed a $1.95 billion deal with Pfizer Inc. for production and delivery of 100 million doses of its experimental COVID-19 vaccine, the U.S. Department of Health and Human...To view the full article, register now.
Already a subscriber? Click here to view full article